Text Size
157 studies found for:    Open Studies | "Psoriasis"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting Tofacitinib Ointment For Chronic Plaque Psoriasis
Conditions: Psoriasis Vulgaris;   Psoriasis
Interventions: Drug: tofacitinib ointment 20 mg/g;   Drug: tofacitinib ointment 10 mg/g;   Drug: placebo ointment (vehicle)
2 Recruiting Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
Conditions: Psoriasis Vulgaris;   Plaque Psoriasis
Intervention: Drug: Daivobet® Gel
3 Unknown † Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
Conditions: Psoriasis;   Psoriasis Vulgaris
Intervention:
4 Recruiting Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients
Condition: Psoriasis, Plaque-type Psoriasis
Interventions: Drug: secukinumab;   Drug: placebo
5 Not yet recruiting A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
6 Recruiting Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis
Condition: Psoriasis
Interventions: Drug: MOL4239;   Drug: Placebo
7 Recruiting The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients
Conditions: Psoriasis;   Obesity
Intervention: Behavioral: Weight Loss
8 Recruiting A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
Conditions: Plaque Psoriasis;   Psoriatic Arthritis;   Pustular Psoriasis (Excluding a Localized);   Psoriatic Erythroderma
Intervention: Drug: TA-650
9 Recruiting Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
Condition: Moderate to Severe Plaque-type Psoriasis
Interventions: Drug: Secukinumab (AIN457);   Drug: Placebo
10 Recruiting PsoBest - The German Psoriasis Registry
Conditions: Psoriasis;   Psoriatic-arthritis
Intervention:
11 Recruiting Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: TSO 2500;   Drug: TSO 7500
12 Recruiting BOSTRIP: Biomarkers of Systemic Treatment Response in Psoriasis
Condition: Psoriasis
Intervention: Other: Withdrawal of venous blood samples
13 Recruiting A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: ASKP1240;   Drug: Placebo
14 Recruiting Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
Conditions: Psoriasis;   Psoriatic Arthritis
Interventions: Drug: Apremilast 30 mg;   Drug: Etanercept 50 mg;   Drug: Placebo tablet;   Drug: Placebo injection (saline)
15 Recruiting A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: CP-690,550
16 Recruiting A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: CNTO 1959;   Drug: Placebo
17 Unknown † Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
Conditions: Tuberculosis;   Psoriasis
Intervention: Other: Tuberculin skin test and Quantiferon -TB Gold test
18 Recruiting Premature Coronary Artery Disease (CAD) in Severe Psoriasis
Conditions: Psoriasis;   Coronary Artery Disease
Intervention: Procedure: CCTA Scan (Coronary CT Angiogram)
19 Recruiting The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis
Condition: Psoriasis
Interventions: Drug: liraglutide;   Drug: Placebo
20 Recruiting The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
Condition: Psoriasis
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years